Rihab Bouchareb
Cardiovascular Research Center,
Department of Medicine,
Division of Nephrology,
Department of Medicine, Division of Nephrology
The Icahn School of Medicine at Mount Sinai
Dr. Rihab Bouchareb is currently an instructor at the Icahn School of Medicine at Mount Sinai, New York (ISMMS). She was graduated from the Institute of Genetics and Molecular and Cellular Biology (IGBMC) at Strasbourg University in France, where she received her Master’s and Ph.D. degrees in Cell and Molecular biology. Her Ph.D. was focused on studying the molecular mechanism leading to atherosclerosis plaque rupture and platelet activation. After completing her post-doctoral training at Quebec Heart and Lung Institute, Laval Hospital, Quebec, Canada, she joined the cardiovascular research center of Mount Sinai as a postdoc. Her research program currently focuses on identifying the molecular signaling pathways that are involved in the calcification of the aortic valve and atherosclerotic plaques.
Boron improves cardiac contractility and fibrotic remodeling following myocardial infarction injury.
Scientific reports 10, 2020 | Pubmed ID: 33051505
Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling.
Pharmacological research May, 2021 | Pubmed ID: 33524540
Proteomic Architecture of Valvular Extracellular Matrix: FNDC1 and MXRA5 Are New Biomarkers of Aortic Stenosis.
JACC. Basic to translational science Jan, 2021 | Pubmed ID: 33532664
Resistin deletion protects against heart failure injury by targeting DNA damage response.
Cardiovascular research 06, 2022 | Pubmed ID: 34324657
Platelets: Implications in Aortic Valve Stenosis and Bioprosthetic Valve Dysfunction From Pathophysiology to Clinical Care.
JACC. Basic to translational science Dec, 2021 | Pubmed ID: 35024507
Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?
Journal of clinical medicine Jun, 2022 | Pubmed ID: 35743402
